Nanotechnology-based Approaches Research Articles

A systematic overview of strategies for photosensitizer and light delivery in antibacterial photodynamic therapy for lung infections.

Antimicrobial photodynamic therapy (aPDT) emerges as a viable treatment strategy for infections resistant to conventional antibiotics. A complex interplay of factors, including intracellular photosensitizer (PS) accumulation, photochemical reaction type, and oxygen levels, determines the efficacy of aPDT. Recent progress includes the development of modified PSs with enhanced lipophilicity and target-specific strategies to improve bacterial cell wall penetration and targeting. Nanotechnology-based approaches, such as using nanomaterials for targeted PS delivery, have shown promise in enhancing aPDT efficacy. Advancements in light delivery methods for aPDT, such as transillumination of large lesions and local light delivery using fiber optic techniques, are also being explored to optimize treatment efficacy in clinical settings. The limited number of animal models and clinical trials specifically designed to assess the efficacy of aPDT for lung infections highlights the need for further research in this critical area. The potential prospects of aPDT for lung tissue infections originating from antibiotic-resistant bacterial infections are also discussed in this review.

Nanotechnology-based approaches for targeted drug delivery for the treatment of respiratory tract infections

Background: Nanotechnology has emerged as a promising field for the diagnosis, monitoring, and treatment of respiratory tract infections (RTIs). By leveraging the unique properties of nanoscale delivery systems, nanotechnology can significantly enhance the selectivity and efficacy of antimicrobials, thereby reducing off-target effects. Objective: This review explores the development and application of targeted nanosystems in combating viral, bacterial, and fungal RTIs. Nanotechnology-based systems, including biological and non-biological nanoparticles, offer innovative solutions for overcoming antimicrobial resistance, improving drug bioavailability, and minimizing systemic side effects. RTIs are a leading cause of morbidity and mortality globally, particularly affecting vulnerable populations such as children, the elderly, and immunocompromised individuals. Traditional drug delivery methods face numerous challenges, such as rapid clearance, poor tissue penetration, and drug degradation. Nanoparticle-based delivery systems address these issues by enhancing tissue penetration, providing sustained drug release, and enabling targeted delivery to infection sites. These systems include liposomal delivery, polymeric nanoparticles, dendrimers, and metal-based nanoparticles, each offering unique advantages in treating RTIs. Nanotechnology also plays a crucial role in vaccine development by offering new strategies to enhance immune responses and improve antigen delivery. Furthermore, the review discusses the clinical translation and regulatory considerations for nanotechnology-based drug delivery, emphasizing the need for rigorous testing and quality control to ensure safety and efficacy. Conclusion: Nanotechnology offers promising advancements in the treatment, and prevention of RTIs by enhancing drug delivery and efficacy. By addressing challenges such as antimicrobial resistance and poor tissue penetration, nanotechnology-based systems have the potential to significantly improve patient outcomes.

Green synthesized Cr2O3/Bi2O3 nanocomposites for gamma ray shielding

The quest for advanced materials in gamma radiation shielding has spurred the exploration of environmentally friendly, nanotechnology-based approaches. This study introduces a novel synthesis of Cr2O3/Bi2O3 nanocomposites (NCs) using the solution combustion method, with Aloe vera extract serving as a natural reducing agent. Comprehensive analytical characterization of the synthesized NCs was conducted using powder X-ray diffraction (PXRD), scanning electron microscopy (SEM), energy-dispersive X-ray spectroscopy (EDS), Fourier-transform infrared spectroscopy (FTIR), and ultraviolet–visible (UV–Vis) spectroscopy. The gamma radiation shielding properties of the Cr2O3/Bi2O3 NCs are evaluated using a NaI(Tl) detector connected to a multichannel analyzer. Key shielding parameters, including mass attenuation coefficients, mean free path, half-value layer, tenth-value layer, energy buildup factor, and radiation protection efficiency, indicate that Cr2O3/Bi2O3 NCs are highly effective in gamma radiation shielding. The results demonstrated the feasible shielding performance of these nanocomposites across various energies within error limits of 5 %. This study highlights the potential of Cr2O3/Bi2O3 NCs as a promising, sustainable alternative to conventional shielding materials, offering enhanced gamma radiation protection with reduced environmental impact.

Role of Natural Polymers in Novel Drug Delivery Systems

Natural polymers have gained significant attention in the field of drug delivery due to their inherent biocompatibility, biodegradability, and low toxicity. This review article aims to provide a comprehensive overview of the diverse roles that natural polymers play in the development of novel drug delivery systems. Beginning with a classification of natural polymers based on their origin (plant, animal, microbial), we explore their unique characteristics and advantages over synthetic counterparts. The review discusses the pivotal role of natural polymers in formulating various drug delivery systems, including sustained/controlled release formulations, targeted delivery platforms, mucoadhesive systems, and nanotechnology-based approaches. Techniques such as emulsification, ionotropic gelation, coacervation, and electrospinning for natural polymer-based drug delivery are elucidated, highlighting their versatility and applicability across different administration routes. Furthermore, we delve into the diverse applications of natural polymers in drug delivery, encompassing oral, transdermal, ocular, injectable, nasal, buccal, and vaginal delivery routes. Recent advances and innovations in combining natural polymers with synthetic counterparts, incorporating stimuli-responsive properties, and personalized medicine approaches are also explored. Despite the numerous advantages offered by natural polymers, challenges such as variability in polymer properties, standardization issues, scale-up challenges, and regulatory considerations are discussed. The review concludes with future perspectives, highlighting emerging trends and opportunities for further research and development in the field of natural polymer-based drug delivery systems. Overall, this review provides valuable insights into the pivotal role of natural polymers in advancing drug delivery technology, paving the way for safer, more efficient, and patient-friendly therapeutic interventions.

Nanocrystals: a new herald for the management of Alzheimer’s disease

Alzheimer’s disease (AD) impairs mental development and interrupts neurocognitive functions that escalate with time leading to death. With continuous evolution in lifestyle and progression of age, the prevalence of AD is progressively rising, leading to a significant economic burden. Thus, effective therapeutic approaches are indeed necessary to address this growing concern. Current treatment regimens primarily help to relieve the symptoms, nevertheless, with nanotechnology-based approaches the nerve damage can be regressed along with a reduction in inflammation and improved brain delivery. Researchers and healthcare professionals are working diligently to develop innovative treatments and interventions to improve the quality of life for individuals affected by AD. This review paper aims to provide comprehensive insights on disease pathogenesis, FDA-approved treatment, recent advancements in drug therapy, and innovative formulation approaches along with an update on drugs in different clinical phases. The review specifically highlights nanocrystals-based formulations and their ability to minimize side effects, improve drug bioavailability, pharmacodynamics and pharmacokinetics. The current review also prospects of role of NCs in enabling drug delivery across BBB and it dives deep to understand its potential to carve out directions in this niche area of treating AD.

Systemic Codelivery of Thymoquinone and Doxorubicin by Targeted Mesoporous Silica Nanoparticle Sensitizes Doxorubicin-Resistant Breast Cancer by Interfering between the MDR1/P-gp and miR 298 Crosstalk.

Multi drug resistance (MDR) in breast carcinoma still poses a significant impairment to successful chemotherapy. As the arsenal of anticancer agents increases with improved preclinical methods, the growth of therapeutic drug combinations is now unprecedented. The malignancies addressed by mono drugs often fail to limit cancer progression, resulting in resistant cancer, thereby offering combinatorial therapies a terrific edge over monodrug regimes. However, the selection of drug combinations required enough preliminary evidence for their synergistic effect. The fundamental mechanisms of MDR to chemotherapeutics are associated with the overexpression of membrane efflux pumps, alternations in drug targets, and increased drug metabolism. Unfortunately, it is very difficult for drugs to overcome resistance produced on their own or by another different drug action. In this context, herein, we report a simple delivery system for coencapsulation and intracellular codelivery of dual-drug thymoquinone (TQ) and doxorubicin (DOX) to resensitize DOX-resistant MDA MB231 cell line (231 R). The 231 R cell line developed in our lab showed an enhanced expression of the ATP-binding cassette (ABC) transporters P-gp1/MDR-1 and a declined miR-298 expression. The present delivery system is based on amine-functionalized mesoporous silica nanoparticles (MSNs), in which the side chain amine functional group was used to react with the carbonyl group of TQ, which acts as a pro-drug system (TQ-MSN) to release TQ and DOX simultaneously. DOX was encapsulated later into the above TQ-MSN by a simple diffusion method. The drugs containing MSNs were further coated with a hyaluronic acid-conjugated PEG-PLGA polymer (HA@TQ-DOX-MSN). This simple nanostrategy interferes with the MDR-1/miR-298 cross-talk, thereby allowing a significant reduction in drug efflux from the cell and highlighting a promising nanotechnology-based combinatorial delivery approach in managing breast cancer chemoresistance.

Recent Advancement in Drug Development for Treating Malaria using Herbal Medicine and Nanotechnological Approach.

More than two hundred million people around the world are infected with malaria, a blood-borne disease that poses a significant risk to human life. Single medications, such as lumefantrine, primaquine, and chloroquine, as well as combinations of these medications with artemisinin or its derivatives, are currently being used as therapies. In addition, due to rising antimalarial drug resistance, other therapeutic options are needed immediately. Furthermore, due to anti-malarial medication failures, a new drug is required. Medication discovery and development are costly and time-consuming. Many malaria treatments have been developed however, most treatments have low water solubility and bioavailability. They may also cause drug-resistant parasites, which would increase malaria cases and fatalities. Nanotechnology may offer a safer, more effective malaria therapy and control option. Nanoparticles' high loading capacity, concentrated drug delivery, biocompatibility, and low toxicity make them an attractive alternative to traditional therapy. Nanotechnology-based anti-malarial chemotherapeutic medications outperform conventional therapies in therapeutic benefits, safety, and cost. This improves patient treatment compliance. The limitations of malaria treatments and the importance of nanotechnological approaches to the treatment of malaria were also topics that were covered in this review. The most recent advancements in nanomaterials and the advantages they offer in terms of medication delivery are discussed in this article. The prospective therapy for malaria is also discussed. Additionally, the limitations of malaria therapies and the importance of nanotechnology-based approaches to the treatment of malaria were explored.

Exploring Protein-Based Carriers in Drug Delivery: A Review.

Drug delivery systems (DDSs) represent an emerging focus for many researchers and they are becoming progressively crucial in the development of new treatments. Great attention is given to all the challenges that a drug has to overcome during its journey across barriers and tissues and all the pharmacokinetics modulations that are needed in order to reach the targeting sites. The goal of these pathways is the delivery of drugs in a controlled way, optimizing their bioavailability and minimizing side effects. Recent innovations in DDSs include various nanotechnology-based approaches, such as nanoparticles, nanofibers and micelles, which provide effective targeted delivery and sustained release of therapeutics. In this context, protein-based drug delivery systems are gaining significant attention in the pharmaceutical field due to their potential to revolutionize targeted and efficient drug delivery. As natural biomolecules, proteins offer distinct advantages, including safety, biocompatibility and biodegradability, making them a fascinating alternative to synthetic polymers. Moreover, protein-based carriers, including those derived from gelatin, albumin, collagen, gliadin and silk proteins, demonstrate exceptional stability under physiological conditions, and they allow for controlled and sustained drug release, enhancing therapeutic efficacy. This review provides a comprehensive overview of the current trends, challenges, and future perspectives in protein-based drug delivery, focusing on the types of proteins adopted and the techniques that are being developed to enhance their functionality in terms of drug affinity and targeting capabilities, underscoring their potential to significantly impact modern therapeutics.

Versatile Approaches of Quantum Dots in Biosensing and Imaging.

Cancer is considered a formidable global health threat, despite substantial strides in diagnosis, detection, and therapeutic strategies. Remarkable progress has been achieved in these realms, yet the survival rates for cancer patients have persisted at suboptimal levels over decades. Acknowledging the need to address the ongoing challenges in cancer survival rates, research efforts are being made to push the boundaries of innovation in diagnostic techniques, bioimaging, and drug delivery technologies. Over the past few years, nano(bio)technology-based approaches have been applied for biosensing and imaging applications to detect biochemical substances in various matrices. Among various nanoengineered particulates, quantum dots (QDs) have been recognized as versatile agents for these applications. QDs, often called artificial atoms, are characterized by the remarkable optical and electrical features which are essential for cytosensing, localized bioimaging and therapeutics. Here in this review, we have discussed various QDs as sensitive and selective agents for precise sensing and imaging of cancer cells. Both electrochemical and optical approaches have been used to describe the cytosensing detection methods. Furthermore, the bioimaging of malignant tumor cells and the drug delivery with therapeutic responses of QDs have also been highlighted. This review also lists the several kinds of QDs that are frequently used for such kinds of applications, such as carbon, graphene, zinc, and other types of hybrid-based QDs. Finally, to shed insight on prospective research, the advantages and potential of QDs are also highlighted. In this article, we also emphasize the limitations and address the difficulties associated with QDs in clinical applications in order to provide insights for potential solutions.

Revolutionizing drug delivery systems: Nanotechnology-based approaches for targeted therapy

Revolutionizing drug delivery systems: Nanotechnology-based approaches for targeted therapy

Engineered Carbon Nanocatalysts for Homocysteine Catabolism

Cystathionine-β-synthase (CBS) deficiency or homocystinuria (HCU) is a rare inherited disorder with main clinical features of osteoporosis, dislocation of the optic lenses, learning difficulties and thromboembolism. CBS is a key enzyme in methionine catabolism pathway. CBS deficiency impairs the conversion of homocysteine (Hcy) to cystathionine, which leads to extracellular buildup of Hcy in toxic concentrations. Patients with CBS deficiency have elevated plasma Hcy and methionine.Currently, there is no FDA approved drug for CBS deficiency. Clinical treatment options are low-protein diet and betaine for severely affected patients, and vitamin supplementation for mildly affected adults. Artificial protein-based enzymes for Hcy treatment are in clinical trials. However, protein-based artificial enzymes can be immunogenic, prone to intracellular modifications, and the treatment may not be viable after few months.We propose a novel nanotechnology-based approach for the treatment of CBS deficiency. Carbon nanomaterials with multiple unsaturated carbons provide an excellent scaffold for engineering enzyme mimicking catalysts. We have designed carbon nanomaterial based catalytic artificial enzymes (CAEs) by surface engineering to mimic metabolic enzymes that catabolize Hcy under physiological conditions. Using a combination of paper chromatography and H1-NMR, our lab has shown that CAE can breakdown homocysteine and produce hydrogen sulfide similar to CGL enzyme. The degree of surface functionalization as well as surface curvature has profound effect on specificity and catalysis. We have shown that CAE can enter cells and lower homocysteine levels in cellular models. In preliminary studies, CAE was able to lower serum homocysteine levels in a murine model. Further studies will involve safety assessments of CAE as a treatment for HCU.

Nanotechnology-based approaches for antibacterial therapy

The technique of antimicrobial therapy action is to stop or slow the growth of bacteria that can kill people, animals, and crops. The most widely used antibacterial agents are antibiotics. Even though these antimicrobial medications are quite effective, there are still certain barriers or challenges in using them effectively. To solve these issues, new antimicrobial drug molecules that don't have side effects or resistance are needed. These days, antimicrobial drugs placed in nanosized vehicles, or nanomedicine, made of different metal and metallic oxides as well as of polymer, carbon or lipid-based may be used to address these issues with conventional therapy and delivery techniques. This review focuses on the importance of nanotechnology in antimicrobial therapy, nanoparticles (NPs) used in this therapy, their mode of action, and the recent advancement in nanotechnology for antimicrobial therapy.

Dynamic interplay of silica-coated iron oxide nanocomposite on soil-plant system to mitigate Cd toxicity in rice

The utilization of nanotechnology based ameliorative strategies has emerged as an effective method to reduce the potential toxicity of environmental stressors on crops. However, there is limited information available regarding the interaction of silica-coated iron oxide nanocomposite (Fe3O4@SiO2, NCs) with plants under abiotic stress. Therefore, the objective of this study was to investigate the effects of different doses of silica-coated iron oxide nanocomposite (NCs) in mitigating Cd phytotoxicity in rice. The results revealed that Cd-contaminated soil inhibited plant growth, reduced physiological attributes, and induced ultrastructural changes in stressed plants. The presence of Cd in the soil also reduced rhizospheric soil pH and soil enzyme activities while increased Cd bioavailability and its uptake in plants. However, the foliar application of silica coated iron oxide NCs stimulated plant biomass production, chlorophyll biosynthesis, and antioxidant capacity. The application of NCs significantly decreased the activities of lipid peroxidation markers (MDA, EL and LOX) and reduced levels of reactive oxygen species (ROS) accumulation (•OH, O2·− and H2O2) in stressed plants. Additionally, NCs application influenced Cd accumulation in different tissues, potentially through modifying chemical profile of root exudates (amino/organic acids), which facilitated Cd precipitation through chelation and its sequestration in vacuoles via modulating the expression of metal transporters. Furthermore, the application of NCs indirectly regulated Cd fractionation, solubility, mobility and Cd enrichment in the rhizosphere. This study demonstrated the effective mitigation of Cd toxicity in rice plants by applying silica-coated iron oxide NCs. The results provided valuable insights into nanotechnology-based approaches for improving plant stress tolerance and offer promising strategies for sustainable agricultural practices.

A Comprehensive Review on Advanced Extraction Techniques for Retrieving Bioactive Components from Natural Sources.

The extraction of bioactive components from natural sources has gained significant attention in recent years due to increasing demand for natural and functional constituents in various industries, including pharmaceuticals, food, and cosmetics. This review paper aims to provide a comprehensive overview of the studies on extracting bioactive components from natural sources using different advanced extraction techniques. It highlights the need for efficient extraction methods to preserve these components' integrity and bioactivity. Various extraction techniques as supercritical-fluid extraction, microwave-assisted extraction, ultrasound-assisted extraction, subcritical solvent extraction, and solid-phase microextraction are explored in detail, highlighting their principles, advantages, and limitations. The review further examines the impact of different factors on the extraction process, including solvent selection, extraction time, temperature, ultrasonication-amplitude, etc. Additionally, emerging techniques, such as green extraction methods and nanotechnology-based approaches, are discussed, emphasizing their potential to enhance the extraction efficiency and sustainability of the process. Furthermore, the review presents case studies and experimental results from recent research articles, providing insights into applying different extraction techniques for specific bioactive components, such as phenolics, flavonoids, alkaloids, and essential oils. It discusses the extraction yield, bioactivity, and potential utilization of the extracted components in various industries. Overall, this review paper is valuable for researchers, scientists, and industry professionals interested in extracting bioactive components from natural sources. It consolidates the current knowledge on different advanced extraction techniques, their optimization parameters, and their potential applications, facilitating further advancements in the field and the development of innovative extraction methods for bioactive component extraction from natural sources.

Synthesis and evaluation of antibacterial and antioxidant effects of propolis nanoparticles and cinnamon nanostructures in preventive dentistry: Experimental and theoretical approaches.

Natural products such as green propolis and cinnamon have been used traditionally in medicine due to their medicinal value. Recently, interest has grown in developing nanotechnology-based approaches to enhance the biological activity of these compounds. This study evaluated the antioxidant and antibacterial properties of macro-sized and nanostructured forms of green propolis and cinnamon against Streptococcus mutans (S.mutans) and the 2,2-diphenyl-2-picrylhydrazyl (DPPH) assay. The sonochemical method was used to synthesize green propolis nanoparticles (PNPs) and cinnamon nanoparticles (CNPs). Their size was confirmed by scanning electron microscopy (SEM) and dynamic light scattering measurements, while they were compared with propolis (P) and cinnamon (C). The antioxidant activity was measured using the DPPH assay, while the minimum inhibitory concentration (MIC) test determined the antibacterial activity against S.mutans. One-way analysis of variance (ANOVA) and Tukey's post hoc tests (α = 0.05) were conducted to analyze the data. Furthermore, docking calculations were carried out to examine the potential of incorporating any new supplements or therapies into your routine. The MIC were 5.46, 21.87, 21.87, and 175 g/L for PNPs, P, CNPs, and C groups, respectively. The PNPs exhibited the most significant antibacterial effect while C was weakest. About antioxidant activity, PNPs and P exhibited significant differences from other groups (P = 0.000 and 0.001, respectively), while CNPs and C showed no significant difference between each other (P = 0.07). The docking calculations revealed a strong interaction between both nanoparticles and S.mutans. The binding energy of dihydroflavonols on propolis nanoparticles was -6.83 kcal/mol, indicating a stable connection.

The Potential o f Gold Nanobipyramids as Anti-Fungal f or Dermatophytes Fungi at Living Animals

Dermatophytes are a group of fungi that cause dermatophytosis, a type of skin infection affecting both humans and animals. While dermatophytosis is typically self-limiting, it can pose significant challenges for individuals with weakened immune systems. Additionally, current treatment options for dermatophytosis have their limitations, including issues of toxicity, inefficacy, and the emergence of drug-resistant strains. Recently, nanotechnology-based approaches have emerged as a promising strategy to overcome the drawbacks of conventional antifungal medications. Gold Nanoparticles (GNPs) have demonstrated substantial antifungal activity against various fungal species, including dermatophytes. Among these, Gold Nanobipyramids (GNBPs) exhibit unique physicochemical properties that enhance their effectiveness against dermatophytes. GNBPs were synthesized using the Seed-Mediated Growth Method (SMGM) due to its simplicity. Optically, GNBPs displayed plasmonic peaks at 1.548 (wavelength 561 nm) and 2.372 (wavelength 807 nm). Structurally, intensity peaks at 38.15° (plane 111) and 44.49° (plane 200) were identified. GNBPs have a surface density of ~70.227±0.530. In the dermatophyte treatment process, GNBPs exhibited varying inhibitory effects. At 40% concentration, fungal growth persisted, with a surface density similar to the no control area. At 60%, inhibition occurred, though less efficiently. The most effective inhibition was observed at 80%, and complete inhibition was achieved at 100% concentration. GNBPs proved successful in inhibiting fungal growth, attributed to their curvature and sharp edges interacting with microbial cell membranes, leading to membrane damage and cellular content leakage.

A review of the prospects, efficacy and sustainability of nanotechnology-based approaches for oil spill remediation.

Numerous marine oil spill incidents and their environmental catastrophe have raised the concern of the research community and environmental agencies on the topic of the offshore crude oil spill. The oil transport through oil tankers and pipelines has further aggravated the risk of the oil spill. This has led to the necessity to develop an effective, environment-friendly, versatile oil spill clean-up strategy. The current review article analyses various nanotechnology-based methods for marine oil spill clean-up, focusing on their recovery rate, reusability and cost. The authors weighed the three primary factors recovery, reusability and cost distinctively for the analysis based on their significance in various contexts. The findings and analysis suggest that magnetic nanomaterials and nano-sorbent have been the most effective nanotechnology-based marine oil spill remediation techniques, with the magnetic paper based on ultralong hydroxyapatite nanowires standing out with a recovery rate of over 99%. The chitosan-silica hybrid nano-sorbent and multi-wall carbon nanotubes are also promising options with high recovery rates of up to 95-98% and the ability to be reused multiple times. Although the photocatalytic biodegradation approach and the nano-dispersion method do not offer benefits for recovery or reusability, they can nevertheless help lessen the negative ecological effects of marine oil spills. Therefore, careful evaluation and selection of the most appropriate method for each marine oil spill situation is crucial. The current review article provides valuable insights into the current state of nanotechnology-based marine oil spill clean-up methods and their potential applications.

Nanotechnology-based Diagnostic Approaches for Early Detection and Monitoring of Polycystic ovary syndrome (PCOS)

Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder affecting reproductive- aged women worldwide, characterized by heterogeneous clinical manifestations and diagnostic challenges. The integration of nanotechnology with diagnostic medicine has paved the way for innovative approaches aimed at improving the early detection and monitoring of PCOS. This review provides a comprehensive overview of nanotechnology-based diagnostic strategies for PCOS, highlighting their principles, advantages, challenges, and clinical applications. Nanoparticle-based biomarkers, nanostructured sensors, molecular imaging techniques, and lab-on-chip devices are among the key nanodiagnostic approaches discussed. The review also addresses the potential implications of nanotechnology in personalized medicine and the translation of these innovative diagnostic tools into clinical practice. Through a critical examination of recent advancements and future prospects, this review underscores the transformative potential of nanotechnology in revolutionizing the diagnosis and management of PCOS.

Synthesis, In-Vitro, In-Vivo screening, and molecular docking of disubstituted aminothiazole derivatives and their selenium nanoparticles as potential antiparkinson agents

Neurological illnesses are among the leading causes of mortality across the world. In the present work, the synthesis of a new series of substituted aminothiazole derivatives (3a-e) as antiparkinsonian agents is reported. Furthermore, aminothiazoles 3a-e were used for in-situ synthesis of selenium nanoparticles 3a(SeNP)-3e(SeNP) to boost the CNS activities and potency. Selenium nanoparticles were confirmed using UV–Vis spectrophotometry, TEM, particle size distribution, and zeta potential. All selenium nano-sized forms elicited greater in-vitro inhibitory activity against both hMAO isoforms when compared to their corresponding normal-sized ones. Compound 3b was the most potent MAO-B inhibitor with an IC50 value of 0.11 µM. Its nano-sized form 3b(SeNP) showed improved hMAO-B inhibitory activity with an IC50 value of 0.033 µM which surpasses its normal-sized action (3b) by 70%. Molecular docking studies of compound 3b displayed interaction at the active sites of both hMAO-A and hMAO-B isoforms in an inhibitory mode similar to co-crystalized ligands. The antiparkinson effect of both 3b and 3b(SeNP) was further screened by using an in-vivo model of haloperidol-induced Parkinson's disease in rats. Behavioral tests in rats revealed that the nanoparticle formulation showed a superior effect on exploratory activity as an antiparkinsonian agent. Accordingly, this nanotechnology-based approach can be a promising lead for developing novel and potent treatments for neurodegenerative diseases.

Applications of Nanotechnology-mediated Herbal Nanosystems for Ophthalmic Drug.

In recent years, herbal nanomedicines have gained tremendous popularity for novel drug discovery. Nanotechnology has provided several advances in the healthcare sector, emerging several novel nanocarriers that potentiate the bioavailability and therapeutic efficacy of the herbal drug. The recent advances in nanotechnology with accelerated strategies of ophthalmic nanosystems have paved a new path for overcoming the limitations associated with ocular drug delivery systems, such as low bioavailability, poor absorption, stability, and precorneal drug loss. Ophthalmic drug delivery is challenging due to anatomical and physiological barriers. Due to the presence of these barriers, the herbal drug entry into the eyes can be affected when administered by following multiple routes, i.e., topical, injectables, or systemic. However, the advancement of nanotechnology with intelligent systems enables the herbal active constituent to successfully entrap within the system, which is usually difficult to reach employing conventional herbal formulations. Herbal-loaded nanocarrier drug delivery systems demonstrated enhanced herbal drug permeation and prolonged herbal drug delivery. In this current manuscript, an extensive search is conducted for original research papers using databases Viz., PubMed, Google Scholar, Science Direct, Web of Science, etc. Further painstaking efforts are made to compile and update the novel herbal nanocarriers such as liposomes, polymeric nanoparticles, solid lipid nanoparticles, nanostructure lipid carriers, micelles, niosomes, nanoemulsions, dendrimers, etc., which are mostly used for ophthalmic drug delivery system. This article presents a comprehensive survey of diverse applications used for the preventative measures and treatment therapy of varied eye disorders. Further, this article highlights the recent findings that the innovators are exclusively working on ophthalmic nanosystems for herbal drug delivery systems. The nanocarriers are promising drug delivery systems that enable an effective and supreme therapeutic potential circumventing the limitations associated with conventional ocular drug delivery systems. The nanotechnology-based approach is useful to encapsulate the herbal bioactive and prevent them from degradation and therefore providing them for controlled and sustained release with enhanced herbal drug permeation. Extensive research is still being carried out in the field of herbal nanotechnology to design an ophthalmic nanosystem with improved biopharmaceutical properties.